$21.00
-1.30-5.83%
Last update: Nov 11, 7:02 AM
Tyra Biosciences Inc
TYRANASDAQ
Tyra Biosciences rose 38.8% from $15.13 to $21.00, ahead of the S&P 500's +9.8%. Its worst day was Aug 5 (−21.0%), and its low came Nov 11 at $15.13.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Tyra Biosciences shares rose 26.4%, while the S&P 500 fell 1.5%.
+26.4%, the year's best day · S&P 500 −1.5%
Tyra Biosciences shares rose 11.0%, while the S&P 500 rose 0.9%.
+11.0% · S&P 500 +0.9%
Story events cover the past 12 months · Times ET
Tyra Biosciences shares rose 14.1%, while the S&P 500 fell 0.3%.
+14.1% · S&P 500 −0.3%
EPS of $-0.57 missed the $-0.53 estimate on $0.00 revenue.
+1.5% · S&P 500 −0.9%
Tyra Biosciences closed at its highest level of the year, 161.8% above where the year started.
+3.5% · S&P 500 +0.1%
EPS of $-0.64 missed the $-0.59 estimate on $0.00 revenue.
+3.8% · S&P 500 +0.6%
EPS of $-0.69 missed the $-0.65 estimate on $0.00 revenue.
−21.0%, the year's worst day · S&P 500 −0.2%
Tyra Biosciences shares fell 17.7%, while the S&P 500 fell 0.5%.
−17.7% · S&P 500 −0.5%
EPS of $-0.74 missed the $-0.66 estimate on $0.00 revenue.
−5.8% · S&P 500 −0.4%
Where it ended: a close of $21.00 on Nov 10, 2026. Up next: Q4 2026 earnings on Mar 1, 2027 (EPS est. $-0.66).
Nothing in the past 12 months.
All TYRA dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TYRA and SPY from Benzinga historical bars. Not investment advice.
